Major factors driving growth of the drug discovery and regenerative medicine markets are increasing public and private investments for R&D, expanded use of organ transplantation procedures, and rising incidence of chronic diseases.  Tissue engineering has advanced rapidly during the recent years.  New types of bio-matrixes and genetically modified cell types plus advanced 3-D printing technology have together transformed this field.

The current workshop will focus on printing technology along with commercial & clinical applications, through scientific presentation and panel discussion.  Experts from Framingham State University, Digilab and Orgenesis will participate in the discussion.  A highly efficient and adoptable commercial printing platform will be introduced and demo during the workshop.  A tour of facilities for the Biotech Master Degree programs (Professional Science Master’s) & (MBA / Biotechnology) will follow after the workshop.